Clinical Trials Logo
  1. Home
  2. Mucositis Oral
  3. NCT05214495

Omega-3 Hydrogel and Prevention of Oral Mucositis

Mucositis Oral Clinical Trial

Official title:
Efficacy of Topical Oral Omega-3 Hydrogel in Prevention of Radiation-induced Oral Mucositis in Head and Neck Cancer Patients: A Randomized Controlled Clinical Trial

Clinical Trial Summary

Oral mucositis (OM) is recognized as one of the most frequent debilitating sequela encountered by head and neck cancer (HNC) patients treated by radiotherapy. The objective of the study is to assess primarily the effect of topical oral Omega-3 hydrogel in prevention of radiation-induced oral mucositis and secondarily, to test the effect of topical oral Omega-3 hydrogel on oral microbiome.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05214495
Study type Interventional
Source Alexandria University
Contact Basma Morsy
Phone 01018222678
Email Basma.Mohamed.dent@alexu.edu.eg
Status Recruiting
Phase Phase 2/Phase 3
Start date February 9, 2022
Completion date September 1, 2022
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04080622 - Evaluate the Efficacy of Selenium for the Prevention of Chemotherapy-induced Mucositis During Autologous Stem Cell Transplantation. Phase 3
Completed NCT03416582 - Feasibility Study of a Nurse Intervention to Impact Mucositis Severity and Prevent Dehydration N/A
Completed NCT03577535 - Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients. Phase 2
Recruiting NCT05278260 - Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients N/A
Recruiting NCT05308732 - Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy Phase 1
Recruiting NCT03461354 - MucoLox Formulation to Mitigate Mucositis Symptoms in Head/Neck Cancer N/A
Completed NCT00293462 - GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer Phase 3
Recruiting NCT04671862 - Photobiomodulation for the Prevention of Radiation Induced Oral Mucositis N/A
Completed NCT04187222 - Effect of Probiotic Use Bifidobacterium Animalis Subsp. Lactis in Peri-implant Mucositis Phase 3
Completed NCT05307445 - Treatment of Peri-Implant Mucositis With Standard of Care and Bioptron Hyperlight Therapy N/A
Not yet recruiting NCT05331131 - Efficacy of Ketamine Mouthwash in the Management of Oral and Pharyngeal Toxicity Associated With Head and Neck Chemoradiotherapy: A Phase 2, Simon 2-stage Trial Phase 2
Not yet recruiting NCT04303312 - Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis Phase 3
Not yet recruiting NCT04596410 - Photobiomodulation Protocols in the Analgesia of Chemotherapy-induced Oral Mucositis in Children N/A
Recruiting NCT03983369 - Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children and Young Adults Treated for a Tumoral Disease Phase 3
Not yet recruiting NCT05224882 - Chemotherapy Oral Manifestations and Dental Awareness Among Parents